March 2020

Letter from the Editor

March 1, 2020

The patient experience We are excited to publish the third annual Patient Voice issue. This special publication is dedicated to raising the voice of patients and sharing their insights on topics ranging from drug discovery and development through commercialization. We also have tapped nearly 100 industry experts to learn what the industry is doing to […]

Upfront

March 1, 2020

Teva and Direct Relief Partner to Bring Cancer Medicines to Africa Global HOPE (Hematology-Oncology Pediatric Excellence), a program of Texas Children’s Hospital, Teva Pharmaceutical Industries, and Direct Relief are partnering to provide access to medications in sub-Saharan Africa, where a majority of pediatric cancer and hematology patients do not survive. Under this partnership, Global HOPE […]

HealthTech

March 1, 2020

Apple Working on Preventative Healthcare Technology Trend Watch: Mobile Devices Expand Healthcare Monitoring Capabilities In January, Apple CEO Tim Cook announced the company is investigating in technology that could help identify health risks at an early stage, similar to heart monitoring features introduced with Apple Watch. Current Apple Watch models are equipped with sensors capable […]

Artificial Intelligence

March 1, 2020

AI-Based Blood Test Predicts Neurodegenerative Disease Progression Trend Watch: AI continues to enhance testing, prediction, and diagnosis A new study illustrates that analysis of blood samples through the use of artificial intelligence can be used to predict disease progression. Researchers at The Neuro (Montreal Neurological Institute and Hospital) of McGill University and the Ludmer Centre […]

Last Word

March 1, 2020

USP: 200 Years of Building Trust Ronald Piervincenzi, Ph.D., who has served as CEO of the United States Pharmacopeia (USP) since February 2014, discusses the organization’s evolution over the past 200 years and its strategy for the future. PV: Congratulations on the 200th anniversary of USP. How has the organization evolved over the years? Piervincenzi: […]

The Power of Patients

March 1, 2020

Patient engagement is permeating all spheres of the healthcare ecosystem. On the cover… This month’s cover image is a self-portrait painted by Casey Ford, age 19, who has a rare connective tissue disorder, which is characterized by under-developed, absent, or misplaced/misaligned kneecaps in newborns. Today, Casey is a freshman studying computer science at Lafayette College […]

Patient Gallery

March 1, 2020

Last year, we were honored to feature the art work of Max Schill, now 11, who remains an active patient advocate, and who helped pass the 21st Century Cure Act. We are excited to continue this tradition with this year’s original artwork by 19-year-old Casey Ford. To expand the patient gallery we tapped several patient […]

Driving Patient Engagement

March 1, 2020

A cultural shift throughout pharma is putting patients squarely in the middle of strategic decision-making. Pharmaceutical companies should take a cue from patient advocacy groups to drive patient engagement, and even partner with those advocacy organizations to create better patient experiences with treatment, according to a new survey from Accenture. The survey, which included responses […]

Patient Stories Can Bridge the Gap Between Pharma and Patients

March 1, 2020

Patients are sharing their stories in an effort to educate other stakeholders, and the pharma industry is using that knowledge sharing to improve on messaging and patient interaction. Patient stories are being used to illustrate organizations’ brand, services, and successes. Hospitals are using them to inform and attract patients. Healthcare systems, clinics, and physicians are […]

Patient-Enhanced Drug Discovery and Development

March 1, 2020

Patients are uniquely positioned to inform the understanding of the therapeutic context for drug development and evaluation. In other industries, it would seem odd not to get input from the end user of a product throughout the development stages. But it seems that pharmaceutical companies — some would say belatedly — are now waking up […]

Bringing the Patient Voice into Clinical Trials

March 1, 2020

In an effort to put patients at the center, pharmaceutical companies are starting to gather input from patients earlier in the clinical trial process. Amid growing recognition that patients need to be part of the decision-making process in order to increase the effectiveness of the study, the pharmaceutical industry has begun to include patient input […]

Building Advocacy Partnerships

March 1, 2020

The relationship between pharma companies and advocacy groups is important for all stakeholders but more needs to be done to create truly interactive, transparent relationships. The most effective approach for pharma companies to truly be patient-minded is a combination of engaging with patients and caregivers while building trusting, sustained relationships with the advocacy groups that […]

Patient Relationships: Physicians and Payers

March 1, 2020

Patients are taking an active role in developing relationships with all stakeholders within their healthcare environment. Over the past several years, the relationship between pharma companies and patients has garnered much of the industry’s attention. But as patients become more empowered, engaged, and experienced in managing their own healthcare needs, they are forcing other stakeholder […]

Chief Patient Officers and Advocates

March 1, 2020

More and more companies are elevating patient-facing roles to the C-Suite; as a result these key roles continue to expand and evolve. Jayne Gershkowitz Chief Patient Advocate Amicus Therapeutics The New C-Suite Role The chief patient role is actually new compared with other C-suite industry positions. While many more companies are increasingly listening to patients […]

SHOWCASE: Real-World Evidence Comes of Age

March 1, 2020

Whether for product development, to support clinical trial designs, for regulatory compliance, or for commercial purposes, real-world data and real-world evidence are helping to transform pharmaceutical decision-making. The legal and regulatory environment is supportive of real-world data (RWD) and real-world evidence (RWE), which is expanding the use of these data sets in new ways. Under […]

Ask the Experts: How Does Real World Evidence Ensure Market Access?

March 1, 2020

Our healthcare system has experienced a fundamental shift in stakeholders’ perceptions of product value and evidentiary thresholds to demonstrate comparative effectiveness, as well as a willingness by relevant decision makers to pay. This value-and-evidence-based landscape is now relying heavily on establishing real-world differentiation and has led to exponential growth in the demand for and conduct […]

RWE is the Future of Clinical Research: Time to Get Onboard

March 1, 2020

We’ve been talking about the value of real-world evidence (RWE) for years. A myriad of new data sources is being developed and linked, and a core set of analytic tools are coming into use. We now see real-world data running the gamut from patient-generated data collected through wearables and social media, to electronic medical records, […]

A Different Kind of Real-World Evidence: The Key Role That Patient-Provider Dialogue Research Can Play

March 1, 2020

All roads in healthcare lead to and from the medical visit. Well, maybe not all roads, but nearly all. The medical visit is central to the overarching healthcare structure and it is driven by the dialogue between patient and provider. The healthcare data and research landscape has been changing significantly over the past few years. […]

Patient Heroes

March 1, 2020

The definition of a hero is a person who is admired for courage, outstanding achievements, or noble qualities. There is a massive demand for patient-engagement solutions, with predictions that the market for such solutions will reach $30.36 billion by 2026. Patient needs are not only supported by solutions but also by services, with an Accenture […]

Making the Patient an Extension of the Team

March 1, 2020

The concept of patient-centricity is well embedded throughout EVERSANA and is intrinsically tied to helping the agency’s clients achieve their goals. Kristin LaBounty Phillips believes that the entire agency — with a unified commitment to quality in addressing patients’ needs — embodies the concept of “patient hero.” The VOICE of the patient PERMEATES throughout our […]

Breaking Down Barriers to Bring Patients Equal Access to Top-Quality Care

March 1, 2020

Patients Always The term “patients first” is not enough, rather it’s “patients always” because patients are our North Star through every stage of development — from discovery to clinical trials to approved treatment. Eve Dryer Executive Director, Patient Advocacy Retrophin All patients should have equal access to the best care, regardless of race, culture, education, […]

Clinical Educators Provide Support Along the Whole Patient Journey

March 1, 2020

Team Power The teams of clinical educators at VMS BioMarketing are driven to help patients on a one-to-one basis to manage chronic illnesses — in the field or on the phone each day. Taking A Step-Wise Approach to clinical education There is one club that no one wants to join, but for those who work […]

Executive Perspective: What Clinical technology Can Learn from Electronic Health Records

March 1, 2020

The future of clinical technology encompasses both better adoption of simple solutions and a slower evolution toward new technologies with the focus on the patient at the center. Mike Nolte CEO, Signant Health Early in the adoption of electronic health records (EHRs), some technology leaders recognized the potential of those solutions to change the way […]

FEEDBACK